News

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Pharmaceutical Technology on MSN4d
BeOne Medicines’ BTK degrader gains EMA PRIME designation
The designation was based on the therapy’s novel mechanism and data showing its anti-tumour activity in B-cell malignancies.
Business Wire4d
BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s Macroglobulinemia
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Medicines Agency (EMA) has ...
Pharmaceutical Technology on MSN8d
Gilead wins positive European approval opinion for twice-yearly HIV injection
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Gilead ...
The Press Democrat10d
EU regulator green lights an injectable HIV drug that could help stop transmission
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. LONDON (AP) — The ...
Medscape6d
EMA Reverses Previous Refusal of Kisunla for Alzheimer's
Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...
STAT11d
European regulators endorse Lilly’s Alzheimer’s treatment for certain patients
European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.
Medscape6d
EMA Says No to Knee Cartilage Repair Therapy Jelrix
The European drug authority recommends refusal of marketing authorization due to evidence gaps in quality and efficacy.
Indianapolis Business Journal10d
Lilly gets limited European backing for Alzheimer’s drug
Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...